Business
DarioHealth Reports Strong Second Quarter 2021 Results and Operational Highlights
Total Q2 revenue of $5.3 million increased 46% sequentially and 194% year-over-year Validated B2B expansion by securing new clients in all B2B segments
About this update from Dariohealth Corp.
[{"type":"text","content":"Total Q2 revenue of $5.3 million increased 46% sequentially and 194% year-over-year\n Validated B2B expansion by securing new clients in all B2B segments\n Expanded into the large and underserved digital behavioral health market through the acquisition of wayForward; signed four Behavioral Health employer contracts\n Built strong foundation for a market leading, comprehensive DTx multi chronic condition platform for all key B2B2C stakeholders: payers, providers, and employers\n Ended the second quarter 2021 with cash and cash equivalents of $63.9 million\n Company to host conference call and webcast today, August 16, at 8:30 am ET\n\n\nNEW YORK, Aug. 16, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provided a corporate and commercial update. \n\"During the second quarter and subsequent period, we saw increasing demand for our integrated multi condition digital therapeutics solution, driven in part by the expansion of our metabolic offering into musculoskeletal and pain conditions through the acquisition of Upright Technologies in February 2021 and into behavioral health through the acquisition of wayForward in June 2021,\" stated Erez Raphael, Chief Executive Officer of Dario. \"We believe Dario's offering is the most comprehensive, fully-integrated hyper personalized digital therapeutics suite in the industry, as demonstrated by customer acceptance, and now market acceptance, as well as the fact that approximately two-thirds of our expanded sales pipeline is made of opportunities that include our complete chronic condition management platform.\" \n\"At the same time, the execution of our long term strategic operating plan resulted in several new employer clients, further penetration into the rapidly growing provider's remote patient monitoring (RPM) market, and we believe that a health plan contract is imminent. Equally as important, Dario continues to on-board new patients efficiently and enrollment trends remain strong. We believe that this bodes well for new clients anticipated throughout the remainder of the third and fourth quarter this year.\"\n\"We had solid financial performance, with Q2 2021 total revenue growth of 46% sequentially from the first quarter of 2021 and 194% over the comparable...